Skip to main content

and
  1. Article

    Open Access

    Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma

    BET-bromodomain inhibition (BETi) has shown pre-clinical promise for MYC-amplified medulloblastoma. However, the mechanisms for its action, and ultimately for resistance, have not been fully defined. Here, usi...

    Pratiti Bandopadhayay, Federica Piccioni, Ryan O’Rourke in Nature Communications (2019)